Group 1 - T. Rowe Price Associates, Inc. and its Affiliates increased their stake in Tongcheng Travel (00780.HK) by purchasing 981,200 shares at an average price of HKD 22.235 per share, totaling approximately HKD 21.817 million [1] - Following this transaction, T. Rowe Price's total shareholding in Tongcheng Travel reached 164,651,600 shares, raising their ownership percentage from 6.97% to 7.00% [1]

Core Viewpoint - The actual controller of Feiwo Technology plans to increase its shareholding in the company through a centralized bidding method, with a total investment amount between RMB 40 million and RMB 70 million [1] Group 1: Shareholding Increase - Shanghai Feiwo Investment Management Co., Ltd., controlled by the actual controller of Feiwo Technology, intends to increase its shareholding within six months from the announcement date [1] - The share purchase will not have a set price range, indicating flexibility in the acquisition strategy [1] - The total amount for the share increase is planned to be no less than RMB 40 million and no more than RMB 70 million [1] Group 2: Financing Support - Industrial Bank Co., Ltd. Changsha Branch has issued a loan commitment letter to Shanghai Feiwo, promising to provide a special loan for the share increase [1] - The loan amount is capped at RMB 50 million, with a maximum term of three years [1]

Core Viewpoint - The actual controller of Feiwo Technology plans to increase its stake in the company through a centralized bidding process within six months, with a minimum investment of RMB 40 million and a maximum of RMB 70 million [1] Group 1: Shareholding Increase Plan - The planned increase in shareholding will not exceed 2% of the company's total share capital [1] - There is no set price range for the share purchase [1] - The funding sources for the increase include self-owned funds and a special loan for shareholding increase [1] Group 2: Loan Commitment - Industrial Bank Co., Ltd. Changsha Branch has issued a loan commitment letter for an amount not exceeding RMB 50 million [1] - The loan term will not exceed three years [1]

Core Viewpoint - The company has updated its share buyback plan, indicating confidence in its long-term growth and market performance, as the current stock price is perceived to be below its true value [1] Group 1: Share Buyback Plan - The updated share buyback plan allows the company to repurchase up to 25,461,295 shares over a period of 50 trading days starting from November 13, 2025 [1] - The total shares to be repurchased, including those already bought back in 2025, will represent 5% of the total issued shares as of the authorization date [1] Group 2: Management Confidence - The board believes that the share buyback plan reflects the confidence of the directors and senior management in the company's long-term growth and market performance [1] - The board asserts that the buyback plan is in the best interest of the company and its shareholders [1] Group 3: Shareholder Activity - The company has been informed that Yijie Biotechnology Holdings Limited and its concert parties have cumulatively purchased 100,000 shares between November 6 and November 10, 2025 [1] - Following this purchase, the concert group holds a total of 218,048,730 shares, representing approximately 37.92% of the total issued shares (excluding treasury shares) [1] - The board views this increase in shareholding as a sign of confidence from major shareholders regarding the company's prospects and growth potential [1]

Group 1 - The company Kintor Pharmaceutical (02171) has updated its share buyback plan to repurchase up to 25,461,295 shares within 50 trading days starting from November 13, 2025 [1] - The updated buyback plan represents 5% of the total issued shares as of the authorization date in 2025, including shares already repurchased in 2025 [1] - The board believes that the current share price is below its true value and does not adequately reflect the company's business prospects, indicating confidence in long-term growth and market performance [1] Group 2 - The board has been informed that Eucure Biopharma and its concert parties have cumulatively purchased 100,000 shares between November 6 and November 10, 2025 [1] - Following this acquisition, Eucure and its concert parties hold a total of 218,048,730 shares, representing approximately 37.92% of the total issued shares as of the announcement date, excluding treasury shares [1]

Core Viewpoint - The company, Zhejiang Nong Group Co., Ltd., announced the progress of its major shareholder's stock buyback plan, indicating confidence in the company's long-term investment value and future development prospects [1][2]. Group 1: Buyback Plan Overview - The buyback plan initiated by the controlling shareholder's action group, Xinghe Group, aims to acquire between 0.50% and 1.00% of the company's total shares within a six-month period from August 12, 2025, to February 11, 2026, at a price not exceeding 9.80 yuan per share [1]. - The announcement of the buyback plan was made on August 12, 2025, and detailed in a public disclosure [1]. Group 2: Progress of the Buyback Plan - As of November 11, 2025, Xinghe Group has acquired a total of 2,652,110 shares, representing 0.52% of the company's current total shares, with a total investment of 24,340,798 yuan [2]. - Following this acquisition, Xinghe Group holds 58,219,287 shares, accounting for 11.43% of the total shares, while the total shares held by the controlling shareholder's action group amount to 222,424,302 shares, or 43.65% of the total [2]. Group 3: Compliance and Future Actions - The buyback actions comply with relevant laws and regulations, including the Securities Law and the Management Measures for the Acquisition of Listed Companies [3]. - Xinghe Group has committed to completing the buyback plan within the specified timeframe and will not reduce its holdings for six months following the completion of the plan [3][4]. - The buyback will not affect the company's share distribution or control [4].

Core Viewpoint - The announcement details the share pledge and release activities of Henan Blue Sky Gas Co., Ltd. and its controlling shareholder, Blue Sky Group, indicating a significant level of pledged shares and ongoing shareholding adjustments. Group 1: Share Pledge and Release - Blue Sky Group holds 317,704,340 shares of the company, accounting for 44.46% of the total share capital, with a cumulative pledge of 246,260,000 shares, representing 77.51% of its holdings and 34.46% of the company's total shares [2] - As of the report date, the actual controller, Li Xinhua, has pledged 46,760,000 shares, with a total pledge by Blue Sky Group and Li Xinhua amounting to 290,260,000 shares, which is 79.64% of their combined holdings and 40.62% of the company's total shares [2] - Recently, Blue Sky Group released the pledge of 5.4 million shares while pledging an additional 7.1 million shares to China Bank, with all related registration procedures completed [2][3] Group 2: Pledge Details and Financial Implications - The total number of pledged shares due within the next six months is 22,256,000, representing 31.14% of the company's total shares, with a corresponding financing amount of 1.701 billion [4] - For the next year, excluding the aforementioned six-month pledges, an additional 3,520,000 shares are due, accounting for 4.93% of the total shares, with a financing amount of 240 million [4] - Blue Sky Group's credit status is reported as good, with sufficient repayment capacity from self-owned funds, investment income, and dividends, indicating no immediate risk of forced liquidation [5] Group 3: Impact on Company Operations - The share pledges by Blue Sky Group are not expected to significantly impact the company's operations, main business, financing costs, or ongoing viability [5] - The pledges involve freely tradable shares, and Blue Sky Group's strong credit status suggests that the risks associated with these pledges are manageable, with no threat to its controlling shareholder status or corporate governance structure [5] - Blue Sky Group does not have any performance compensation obligations related to these pledges [6]

Core Viewpoint - The company announced that its non-independent directors, supervisors, senior executives, and other management personnel have completed a share buyback plan, which was initially set to start on May 6, 2025, for a duration of six months, with a minimum investment of 20.73 million yuan [1] Summary by Categories Share Buyback Details - A total of 22 individuals participated in the buyback plan, acquiring 3.0175 million shares, which represents 0.1544% of the total share capital [1] - The total amount invested in the buyback reached 20.8548 million yuan [1] - Among the participants, 11 non-independent directors contributed 14.6835 million yuan, while the other 11 management personnel invested 6.1713 million yuan [1] Compliance and Control - The share buyback will not affect the company's compliance with listing conditions or lead to any changes in control [1] - The buying entities are committed to not selling their shares within the six-month period following the buyback [1]

Core Viewpoint - The announcement details the progress of the shareholding increase plan by certain directors and senior management of Anhui Sierte Fertilizer Co., Ltd, highlighting their commitment to the company's long-term value and strategic development [2][6]. Summary by Sections 1. Basic Situation of the Increase Plan - The company disclosed a shareholding increase plan on September 16, 2025, where the chairman and general manager Yuan Qirong, vice general manager Yuan Peng, and board secretary Wu Changhao planned to increase their shares within three months [2]. - Yuan Qirong intends to invest between RMB 3 million and RMB 6 million, Yuan Peng between RMB 500,000 and RMB 1 million, and Wu Changhao between RMB 250,000 and RMB 500,000 [2][8]. 2. Progress of the Increase Plan - As of the report date, over half of the increase plan's time has elapsed, with Yuan Qirong acquiring 530,700 shares (0.062% of total shares) for RMB 2.7331 million, Yuan Peng acquiring 98,000 shares (0.011%) for RMB 511,700, and Wu Changhao acquiring 50,000 shares (0.006%) for RMB 261,300 [3][4][12]. 3. Main Content of the Increase Plan - The purpose of the increase is based on confidence in the company's strategic development and long-term investment value [6]. - The shares will be acquired through centralized bidding, using personal funds, without a set price range, and will be executed within three months from the announcement date [7][8]. 4. Implementation Details - The increase plan will not affect the company's compliance with listing conditions or control changes [13]. - The company will continue to monitor the progress of the increase plan and fulfill information disclosure obligations as required [14].

Core Viewpoint - Binhua Co., Ltd. announced that its investment partner, Binzhou and Yi Industry Investment Partnership (Limited Partnership), is confident in the company's future and recognizes its value, leading to an increase in shareholding [1] Summary by Sections Shareholding Increase - From September 3 to November 4, 2025, the investment partner increased its holdings by 17,949,300 shares, accounting for 0.87% of the total share capital [1] - After this transaction, the partner holds a total of 206 million shares, representing 10% of the total share capital [1] Financial Commitment - As of the report signing date, the partner has cumulatively increased its holdings by 60,005,600 shares, with an investment amount of approximately 246 million yuan [1] - The partner has not completed its shareholding increase plan and intends to continue with the implementation [1] Future Plans - There are no other equity change plans for the next 12 months [1]